Recruiting
High-Intensity Interval Versus Moderate-Intensity Continuous Water Based Exercise in Hypertensive Older Individuals
This study will investigate the acute and chronic effects in hemodynamic and autonomic variables to high-intensity interval versus moderate-intensity continuous heated water-based exercise in older individuals with hypertension.
ClinicalTrials.gov IDNCT04126785
PhaseNA
Enrollment60
SponsorUniversidade Estadual Paulista Júlio de Mesquita Filho
Age60 Years
SexALL
Conditions studied
Hypertension
About this study
This study will investigate the acute and chronic effects in hemodynamic and autonomic variables to high-intensity interval versus moderate-intensity continuous heated water-based exercise in older individuals with hypertension.
Interventions
- Other: High Intensity Interval Exercise in Heated Water-Based — High intensity interval exercise will perform at controlled heated water-base (30 e 32 ºC). Subject will be submerged at the xiphoid process level. The session will consist in 4 min walking (warm-up) at 9 level of rate perceived exertion (RPE) scale, followed by 21 min of HIIE, alternating 1 min of jogging/running at 15-17 (hard-very hard) level with 2 min of walking at 9-11 (very light-fairly light) level of RPE.
- Other: Continuous Moderate Exercise in Heated Water-Based — Continuous moderate exercise will perform at controlled heated water-base (30 e 32 ºC). Subject will be submerged at the xiphoid process level. The session will consist in 4 min walking (warm-up) at 9 level (light) of RPE, followed by 26 min of MICE, walking at 11-13 (fairly light)level of RPE.
- Other: Control Group — CON session will perform at controlled heated water-base (30 e 32 ºC). Subject will be seated in a chair and submerged at the until xiphoid process level for 30 min.
Primary outcomes
- Change from baseline Blood Pressure (Systolic and Diastolic) following 12 weeks of exercise. (12 weeks)
Eligibility information
Inclusion Criteria:
* ≥60 years old;
* Hypertension diagnosed at least 6 months earlier (stage 1 or 2);
* Antihypertensive drug treatment and without dosage alteration at least 3 months earlier;
* Blood pressure inferior to 140/90 mmHg in medical office.
Non-inclusion criteria:
* Smoking individuals;
* Uncontrolled cardiovascular disease;
* Disability;
* Deficit cognitive;
Exclusion Criteria:
* Non 100% participation;
* Change (or stopped) clinical or drug treatment.
Study locations
- São Paulo State Univeristy, Bauru, São Paulo 17033360 Brazil
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.